Advertisement

Woran stirbt der Intensivpatient?

  • L. Frey
  • K. Meßmer
Conference paper
Part of the Langenbecks Archiv für Chirurgie book series (DTGESCHIR, volume 1996)

Zusammenfassung

Die Leistungen der Intensivmedizin werden heute von verschiedenen Standpunkten aus beurteilt: Der Erfolg für den individuellen Patienten wird daran gemessen, ob der Patient überlebt. In neueren Untersuchungen wird nunmehr auch der funktionelle Status und die Lebensqualität des Patienten nach der Intensivtherapie in die Abschätzung des Therapieerfolgs miteinbezogen. Die detaillierte Beurteilung der Lebensqualität des Patienten nach der akuten Behandlung soll unter Berücksichtigung seiner funktionellen, psychischen und sozialen Kompetenz eine objektive individuelle Erfolgsabschätzung ermöglichen.

What Is the Cause of Death in Intensive Care Patients?

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Knaus WA, Draper EA, Wagner DP et al. (1985) APACHE II: A severity of disease classification system. Crit Care Med 13:818–829PubMedCrossRefGoogle Scholar
  2. 2.
    Knaus WA, Wagner DP, Draper EA et al. (1991) The APACHE III prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100:1619–1636PubMedCrossRefGoogle Scholar
  3. 3.
    Seneff M, Knaus WA (1989) Predicting patient outcome from intensive care: a guide to APACHE, MPM, SAPS, PRISM, and other prognostic scoring systems. J Intens Care Med 4:33–51Google Scholar
  4. 4.
    Frisho-Lima P, Gurman G, Schapira A et al. (1994) Rationing critical care — what happens to patients who are not admitted? Theory Surg 9:208–211Google Scholar
  5. 5.
    Lewandowsky K, Pappert D, Kuhlen R et al. (1996) Klinische Aspekte des akuten Lungenversa-gens des Erwachsenen (ARDS). Anaesthesist 45:2–18CrossRefGoogle Scholar
  6. 6.
    Warner MA, Hosking MP, Lobdell CM et al. (1988) Surgical procedures among those greater than or equal to 90 years of age. A population-based study in Olmsted County, Minnesota 1975–1985. Ann Surg 207:380–386PubMedCrossRefGoogle Scholar
  7. 7.
    Forst H (1992) Ökonomie als limitierender Faktor der Intensivtherapie im hohen Lebensalter. Chirurg BDC 31:79–81Google Scholar
  8. 8.
    Luce JM (1994) The changing physician-patient relationship in critical care medicine under health care reform. Am J Respir Crit Care Med 150:266–270PubMedCrossRefGoogle Scholar
  9. 9.
    Le Gall J-R, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American Multicenter Study. JAMA 270:2957–2963PubMedCrossRefGoogle Scholar
  10. 10.
    Atkinson S, Bihari D, Smithies M et al. (1994) Identification of futility in intensive care. Lancet 344:1203–1206PubMedCrossRefGoogle Scholar
  11. 11.
    Sauaia A, Moore FA, Moore EE et al. (1995) Epidemiology of trauma deaths: a reassessment. J Trauma Injury Infect Crit Care 38:185–193CrossRefGoogle Scholar
  12. 12.
    Sluis van der CK, Duis ten HJ, Geertzen JHB (1995) Multiple injuries: an overview of outcome. J Trauma Injury Infect Crit Care 38:681 – 686CrossRefGoogle Scholar
  13. 13.
    Pape H-Ch, Remmers D, Kleemann W et al. (1994) Posttraumatic multiple organ failure — a report on clinical and autopsy findings. Shock 2:228–234PubMedCrossRefGoogle Scholar
  14. 14.
    Livingston DH, Mosenthal Ac, Deitch EA (1995) Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview. New Horizons, SCCM 3:257–266Google Scholar
  15. 15.
    Brun-Buisson C, Doyon F, Carlet J et al. (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU group for severe sepsis. JAMA 274:968–974PubMedCrossRefGoogle Scholar
  16. 16.
    Friedman G (1995) Outcome from Septic Shock: have we made progress? 15th Symposium on Intensive Care and Emergency Medicine, Brussels March: 21–24Google Scholar
  17. 17.
    Ziegler EF, Fisher CJ, Sprung CL et al. (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin — A Randomized, Double-Blind, Placebo-Controlled Trial. N Engl J Med 324:429–436PubMedCrossRefGoogle Scholar
  18. 18.
    Vincent J-L, Chamlou R (1996) Sepsis trials. Curr Op Anaesth 9:146–156CrossRefGoogle Scholar
  19. 19.
    Fisher ChJ, Agosti JM, Opal SM et al. (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. New Engl J Med 334:1697–1702PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • L. Frey
    • 1
  • K. Meßmer
    • 1
  1. 1.Institut für Chirurgische ForschungLudwig-Maximilians-Universität München, Klinikum GroßhadernMünchenDeutschland

Personalised recommendations